Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | -3.33% | -6.02% | +15.34% |
Chart calendar Corvus Pharmaceuticals, Inc.
Upcoming events on Corvus Pharmaceuticals, Inc.
Past events on Corvus Pharmaceuticals, Inc.
2024-06-05 03:00 pm | Jefferies Global Healthcare Conference |
2024-05-06 04:30 pm | Q1 2024 Earnings Call |
2024-05-06 04:01 pm | Q1 2024 Earnings Release |
2024-03-19 04:30 pm | Q4 2023 Earnings Call |
2024-03-19 04:02 pm | Q4 2023 Earnings Release |
2024-02-07 | Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No 4278 |
2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract No 1442 |
2023-11-07 04:30 pm | Q3 2023 Earnings Call |
2023-11-07 04:01 pm | Q3 2023 Earnings Release |
2023-09-07 08:30 am | CPI-818 Phase 3 Clinical Trial Results Call |
2023-08-08 04:30 pm | Q2 2023 Earnings Call |
2023-08-08 04:01 pm | Q2 2023 Earnings Release |
2023-06-28 | Japanese Cancer Association and American Association for Cancer Research Precision Cancer Medicine I |
2023-06-15 04:00 pm | Annual General Meeting |
2023-06-15 06:30 am | International Malignant Lymphoma Meeting - Abstract #: 193 |
2023-06-07 09:30 am | Jefferies Global Healthcare Conference |
2023-05-08 04:30 pm | Q1 2023 Earnings Call |
2023-05-08 04:01 pm | Q1 2023 Earnings Release |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No 1813 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -48,9 -50,0 2.2% | -43,8 -43,7 -0.12% | -38,6 -40,8 5.21% | -32,6 -36,9 11.78% | -23,4 -23,6 0.78% | -32,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -46,7 -46,9 0.52% | -6,00 -56,9 89.47% | -43,2 -42,9 -0.82% | -41,3 -42,3 2.36% | -27,0 -26,5 -1.89% | -28,9 |
Net income Million USD | Released Forecast Spread | -46,7 -46,9 0.52% | -6,00 -41,0 85.37% | -43,2 -42,9 -0.82% | -41,3 -42,3 2.36% | -27,0 -26,5 -1.82% | -30,3 |
EPS USD | Released Forecast Spread | -1,59 -1,57 -1.6% | -0,20 -1,39 85.61% | -1,03 -0,98 -4.75% | -0,89 -0,91 2.2% | -0,56 -0,55 -1.82% | -0,48 |
Announcement Date | 05/03/20 | 25/03/21 | 10/03/22 | 28/03/23 | 19/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -7,41 -7,49 1.03% | -7,01 -8,11 13.49% | -12,5 -6,96 -79.1% | -5,67 -10,0 43.41% | -6,57 -6,23 -5.56% | -5,62 -5,97 5.75% | -5,56 -6,09 8.64% | -5,65 -5,83 3.11% | -6,25 -6,41 2.5% | -7,50 | -8,72 | -9,70 | -10,7 | -11,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,30 -7,54 -10.04% | -8,36 -8,09 -3.42% | -14,8 -7,35 -101.77% | -9,82 -10,8 9.19% | -7,87 -7,42 -6.04% | -6,50 -6,48 -0.3% | -6,00 -5,53 -8.55% | -6,65 -6,15 -8.18% | -5,70 -7,36 22.54% | -6,97 | -7,50 | -8,57 | -10,3 | -10,0 |
Net income Million USD | Released Forecast Spread | -8,30 -7,54 -10.04% | -8,36 -8,22 -1.74% | -14,8 -7,35 -101.77% | -9,82 -10,8 9.19% | -7,87 -7,42 -6.04% | -6,50 -6,48 -0.3% | -6,00 -5,98 -0.38% | -6,65 -6,17 -7.89% | -5,70 -6,56 13.06% | -7,26 | -8,12 | -9,18 | -10,3 | -9,70 |
EPS USD | Released Forecast Spread | -0,18 -0,15 -17.39% | -0,18 -0,18 -1.88% | -0,32 -0,16 -104.25% | -0,21 -0,23 8.7% | -0,17 -0,16 -8.51% | -0,14 -0,14 0% | -0,12 -0,12 2.04% | -0,14 -0,13 -10.52% | -0,12 -0,13 7.69% | -0,12 | -0,12 | -0,13 | -0,15 | -0,15 |
Announcement Date | 05/05/22 | 08/08/22 | 03/11/22 | 28/03/23 | 08/05/23 | 08/08/23 | 07/11/23 | 19/03/24 | 06/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Corvus Pharmaceuticals, Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRVS Stock
- Calendar Corvus Pharmaceuticals, Inc.